Mizuho Maintains Buy on CVS Health, Lowers Price Target to $88
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes has maintained a 'Buy' rating on CVS Health (NYSE:CVS), but lowered the price target from $120 to $88.
July 11, 2023 | 11:53 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mizuho has maintained a 'Buy' rating on CVS Health, but lowered the price target from $120 to $88.
The lowered price target could potentially lead to a short-term negative sentiment among investors, but the maintained 'Buy' rating indicates that Mizuho still sees potential in CVS Health's stock in the long term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100